1. Home
  2. RGEN vs ATR Comparison

RGEN vs ATR Comparison

Compare RGEN & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • ATR
  • Stock Information
  • Founded
  • RGEN 1981
  • ATR 1992
  • Country
  • RGEN United States
  • ATR United States
  • Employees
  • RGEN N/A
  • ATR N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • ATR Plastic Products
  • Sector
  • RGEN Health Care
  • ATR Industrials
  • Exchange
  • RGEN Nasdaq
  • ATR Nasdaq
  • Market Cap
  • RGEN 8.2B
  • ATR 9.3B
  • IPO Year
  • RGEN N/A
  • ATR 1993
  • Fundamental
  • Price
  • RGEN $142.30
  • ATR $116.25
  • Analyst Decision
  • RGEN Buy
  • ATR Buy
  • Analyst Count
  • RGEN 11
  • ATR 4
  • Target Price
  • RGEN $170.90
  • ATR $167.50
  • AVG Volume (30 Days)
  • RGEN 1.0M
  • ATR 688.4K
  • Earning Date
  • RGEN 10-28-2025
  • ATR 10-30-2025
  • Dividend Yield
  • RGEN N/A
  • ATR 1.65%
  • EPS Growth
  • RGEN N/A
  • ATR 24.99
  • EPS
  • RGEN 0.03
  • ATR 6.23
  • Revenue
  • RGEN $707,890,000.00
  • ATR $3,662,533,000.00
  • Revenue This Year
  • RGEN $17.50
  • ATR $4.30
  • Revenue Next Year
  • RGEN $12.74
  • ATR $3.85
  • P/E Ratio
  • RGEN $4,625.69
  • ATR $18.66
  • Revenue Growth
  • RGEN 11.74
  • ATR 2.50
  • 52 Week Low
  • RGEN $102.97
  • ATR $103.23
  • 52 Week High
  • RGEN $182.52
  • ATR $178.03
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.45
  • ATR 25.93
  • Support Level
  • RGEN $144.18
  • ATR $103.23
  • Resistance Level
  • RGEN $151.25
  • ATR $116.96
  • Average True Range (ATR)
  • RGEN 6.92
  • ATR 3.82
  • MACD
  • RGEN -2.45
  • ATR -1.00
  • Stochastic Oscillator
  • RGEN 9.42
  • ATR 44.95

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

Share on Social Networks: